Clinical Trials Directory

Trials / Completed

CompletedNCT02297243

Sinopsys Lacrimal Stent Indicated for Sinus Irrigation

The Sinopsys Lacrimal Stent Indicated for Sinus Irrigation Via Transcaruncular Ethmoid Sinus Access in Patients With Moderate to Severe Chronic Rhinosinusitis With Ethmoid Sinus Involvement

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Sinopsys Surgical · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to collect preliminary clinical data related to the safety and performance of the Sinopsys Lacrimal Stent.

Detailed description

For purposes of this clinical study, the Sinopsys Lacrimal Stent is intended to provide a means of administering saline sinus irrigation via a transcaruncular-ethmoid sinus access in patients with moderate to severe chronic rhinosinusitis with ethmoid involvement. The purpose of the administration of saline irrigation is to reduce the intensity of symptoms of chronic rhinosinusitis in this patient population.

Conditions

Interventions

TypeNameDescription
DEVICESinopsys Lacrimal StentThe Sinopsys Lacrimal Stent is indicated for use to create a transcaruncular ethmoid sinus access.

Timeline

Start date
2015-03-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2014-11-21
Last updated
2016-02-12

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02297243. Inclusion in this directory is not an endorsement.